Nicholas Grund - Chief Commercial Officer at Akebia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
AKBA on Nasdaq
All Insider Reports
All Insider Reports

Nicholas Grund - trading volume in the past year for Akebia Therapeutics, Inc.

Holdings reported by Nicholas Grund for Akebia Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 561,750 $780,832 $1.39 02 Feb 2026 Direct
Stock Option (Right to buy) 320,000 30 Jan 2026 Direct Common Stock

Transactions reported by Nicholas Grund for Akebia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.